Yeah, the recent director buying suggests a decent acquisition may be on the way. Lack of Director skin was lacking in the previous iteration so will see what happens from here.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025